IMU 0.00% 10.5¢ imugene limited

I sold my holding last year, and just bought back in...

  1. 9,525 Posts.
    lightbulb Created with Sketch. 309
    I sold my holding last year, and just bought back in today!
    Waiting for my re-entry for sometimes, and I think 1.4c is a reasonable bet on this recent trial results:
    GLTA


    The Phase 1b HER-Vaxx study which completed enrolment in 2018 met all its primary endpoints. The study is ongoing with patients continuing to receive HER-Vaxx every 3 months to maintain high levels of cancer targeting antibodies. A Phase 2 study was initiated in March 2019 dosing patients at the highest Phase 1b dose.The presentation details the continued progress being made by patients who received the highest dose of HER-Vaxx. By day 182 of the trial, their tumours have either shrunk further or stabilized. In one patient, their tumour has shrunk more than 70% since joining the trial. All patients on the highest dose have already received their day 266 doses and these results will be presented in an oral presentation at ESMO GI in Barcelona on 3-6 July 2019.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
176 10004604 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 420568 8
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 28/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.